Fluorescent Immunoassay Market Scope And Analysis

Report Code : TIPRE00011093
Category : Life Sciences

No. of Pages : 150

Buy Now

Fluorescent Immunoassay Market Scope and Analysis Report by 2028

Buy Now

Fluorescent Immunoassay Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 2.81 Billion
Market Size by 2031	US$ 4.51 Billion
Global CAGR (2023 - 2031)	5.8%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Type ELISA Rapid Lateral Flow Immunoassay By Application Infectious Diseases Oncology Cardiovascular Diseases By End User Hospitals and Clinics Diagnostic Centers Pharmaceutical & Biotechnology Companies Academic and Research Institutes
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Abbott BD bioMerieux SA F Hoffman La Roche Ltd Siemens AG Sysmex Corp Thermo Fisher Scientific Inc Quidel Corp Ortho Clinical Diagnostics Holdings plc Danaher

Fluorescent Immunoassay Market News and Recent Developments

The fluorescent immunoassay market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the fluorescent immunoassay market are listed below:

Roche announced that it has launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of SARS-CoV-2 infections. The laboratory-based Elecsys SARS-CoV-2 Antigen test had earlier received CE mark and has recently obtained the import license from CDSCO (Source: F. Hoffmann-La Roche Ltd., Press Release, June 2021)
Ortho Clinical Diagnostics announced its quantitative COVID-19 IgG antibody test achieved CE Mark. Ortho’s VITROS Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization SARS-CoV-2 serological methods. (Source: Ortho Clinical Diagnostics, Newsletter, May 2021)
Ortho Clinical Diagnostics announced the US FDA granted Emergency Use Authorization to its second COVID-19 antibody test—the VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test (COVID-19 IgG antibody test). (Source: Ortho Clinical Diagnostics, Newsletter, April 2021)

Fluorescent Immunoassay Market Report Coverage and Deliverables

The “Fluorescent Immunoassay Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Fluorescent immunoassay market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Fluorescent immunoassay market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Fluorescent immunoassay market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the fluorescent immunoassay market
Detailed company profiles